Matthew John Baggott, Ph.D. - Publications

University of Chicago, Chicago, IL 
cognitive neuroscience, psychopharmacology

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Agurto C, Cecchi GA, Norel R, Ostrand R, Kirkpatrick M, Baggott MJ, Wardle MC, Wit H, Bedi G. Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31978933 DOI: 10.1038/S41386-020-0620-4  0.96
2019 Baggott MJ, Garrison KJ, Coyle JR, Galloway GP, Barnes AJ, Huestis MA, Mendelson JE. Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers. Journal of Psychoactive Drugs. 1-10. PMID 30967099 DOI: 10.1080/02791072.2019.1593560  0.52
2016 Bershad AK, Miller MA, Baggott MJ, de Wit H. The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants? Journal of Psychopharmacology (Oxford, England). PMID 27562198 DOI: 10.1177/0269881116663120  0.96
2016 Baggott MJ, Garrison KJ, Coyle JR, Galloway GP, Barnes AJ, Huestis MA, Mendelson JE. MDMA Impairs Response to Water Intake in Healthy Volunteers. Advances in Pharmacological Sciences. 2016: 2175896. PMID 27403159 DOI: 10.1155/2016/2175896  0.96
2016 Baggott MJ, Coyle JR, Siegrist JD, Garrison KJ, Galloway G, Mendelson JE. Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting. Journal of Psychopharmacology (Oxford, England). PMID 26880224 DOI: 10.1177/0269881115626348  0.96
2015 Baggott MJ, Kirkpatrick MG, Bedi G, de Wit H. Intimate insight: MDMA changes how people talk about significant others. Journal of Psychopharmacology (Oxford, England). 29: 669-77. PMID 25922420 DOI: 10.1177/0269881115581962  0.96
2014 Kirkpatrick MG, Baggott MJ, Mendelson JE, Galloway GP, Liechti ME, Hysek CM, de Wit H. MDMA effects consistent across laboratories. Psychopharmacology. 231: 3899-905. PMID 24633447 DOI: 10.1007/S00213-014-3528-Z  0.96
2014 Mendelson J, Clavier O, Pal R, Kline-Shroder B, Baggott M, Coyle J, Galloway G. Development and testing of a web-enabled cognitive/neuropsychological evaluation system for substance abusers Drug and Alcohol Dependence. 140. DOI: 10.1016/J.Drugalcdep.2014.02.412  0.64
2013 Weafer J, Baggott MJ, de Wit H. Test-retest reliability of behavioral measures of impulsive choice, impulsive action, and inattention. Experimental and Clinical Psychopharmacology. 21: 475-81. PMID 24099351 DOI: 10.1037/A0033659  0.96
2013 Pal R, Balt S, Erowid E, Erowid F, Baggott MJ, Mendelson J, Galloway GP. Ketamine is associated with lower urinary tract signs and symptoms. Drug and Alcohol Dependence. 132: 189-94. PMID 23474358 DOI: 10.1016/J.Drugalcdep.2013.02.005  0.96
2013 Baggott MJ, Childs E, Hart AB, de Bruin E, Palmer AA, Wilkinson JE, de Wit H. Psychopharmacology of theobromine in healthy volunteers. Psychopharmacology. 228: 109-18. PMID 23420115 DOI: 10.1007/S00213-013-3021-0  0.96
2011 Mendelson J, Baggott MJ, Flower K, Galloway G. Developing biomarkers for methamphetamine addiction. Current Neuropharmacology. 9: 100-3. PMID 21886571 DOI: 10.2174/157015911795017128  0.96
2011 Balt SL, Galloway GP, Baggott MJ, Schwartz Z, Mendelson J. Mechanisms and genetics of antipsychotic-associated weight gain. Clinical Pharmacology and Therapeutics. 90: 179-83. PMID 21633343 DOI: 10.1038/Clpt.2011.97  0.96
2011 Li L, Galloway GP, Verotta D, Everhart ET, Baggott MJ, Coyle JR, Lopez JC, Mendelson J. A method to quantify illicit intake of drugs from urine: methamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 338: 31-6. PMID 21450932 DOI: 10.1124/Jpet.111.179176  0.96
2011 Galloway GP, Buscemi R, Coyle JR, Flower K, Siegrist JD, Fiske LA, Baggott MJ, Li L, Polcin D, Chen CY, Mendelson J. A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction. Clinical Pharmacology and Therapeutics. 89: 276-82. PMID 21178989 DOI: 10.1038/Clpt.2010.307  0.96
2011 Mendelson JE, Coyle JR, Lopez JC, Baggott MJ, Flower K, Everhart ET, Munro TA, Galloway GP, Cohen BM. Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial. Psychopharmacology. 214: 933-9. PMID 21140258 DOI: 10.1007/S00213-010-2103-5  0.96
2011 Baggott MJ, Coyle JR, Erowid E, Erowid F, Robertson LC. Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire. Drug and Alcohol Dependence. 114: 61-7. PMID 21035275 DOI: 10.1016/J.Drugalcdep.2010.09.006  0.96
2010 Garrison KJ, Coyle JR, Baggott MJ, Mendelson J, Galloway GP. Imagery scripts and a computerized subtraction stress task both induce stress in methamphetamine users: a controlled laboratory study. Substance Abuse : Research and Treatment. 4: 53-60. PMID 22879743 DOI: 10.4137/Sart.S6019  0.96
2010 Baggott MJ, Siegrist JD, Galloway GP, Robertson LC, Coyle JR, Mendelson JE. Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans. Plos One. 5: e14074. PMID 21152030 DOI: 10.1371/Journal.Pone.0014074  0.96
2010 Galloway GP, Singleton EG, Buscemi R, Baggott MJ, Dickerhoof RM, Mendelson JE. An examination of drug craving over time in abstinent methamphetamine users. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 19: 510-4. PMID 20958846 DOI: 10.1111/J.1521-0391.2010.00082.X  0.96
2010 Flower K, Li L, Chen CY, Baggott MJ, Galloway GP, Mendelson J. Efficacy, safety, and ethics of cosmetic neurology far from settled. Clinical Pharmacology and Therapeutics. 88: 461-3. PMID 20856245 DOI: 10.1038/Clpt.2010.194  0.96
2010 Baggott MJ, Erowid E, Erowid F, Galloway GP, Mendelson J. Use patterns and self-reported effects of Salvia divinorum: an internet-based survey. Drug and Alcohol Dependence. 111: 250-6. PMID 20627425 DOI: 10.1016/J.Drugalcdep.2010.05.003  0.96
2010 Li L, Lopez JC, Galloway GP, Baggott MJ, Everhart T, Mendelson J. Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose. Therapeutic Drug Monitoring. 32: 504-7. PMID 20592647 DOI: 10.1097/Ftd.0B013E3181Db82F2  0.96
2010 Baggott M, Galloway G, Pournajafi-Nazarloo H, Carter CS, Didier R, Jang M, Coyle J, Mendelson J. MDMA (‘Ecstasy’) impairs categorization of brief fearful expressions Journal of Vision. 9: 491-491. DOI: 10.1167/9.8.491  0.64
2010 Mendelson JE, Tolliver BK, Delucchi KL, Baggott MJ, Flower K, Harris CW, Galloway GP, Berger P. Capsaicin, an active ingredient in pepper sprays, increases the lethality of cocaine Forensic Toxicology. 28: 33-37. DOI: 10.1007/s11419-009-0079-9  0.96
2009 Connelly WM, Baggott MJ. Role of endocannabinoids in 5-HT2 receptor-mediated effects. Journal of Neurophysiology. 101: 5-7. PMID 19004992 DOI: 10.1152/Jn.91054.2008  0.96
2009 Dufka F, Galloway G, Baggott M, Mendelson J. The effects of inhaled L-methamphetamine on athletic performance while riding a stationary bike: A randomised placebo-controlled trial British Journal of Sports Medicine. 43: 832-835. PMID 18981044 DOI: 10.1136/Bjsm.2008.048348  0.96
2004 Baggott MJ, Erowid E, Erowid F, Mendelson JE. Use of salvia divinorum, an unscheduled hallucinogenic plant: a web‐based survey of 500 users Clinical Pharmacology & Therapeutics. 75: 72. DOI: 10.1016/J.Clpt.2003.11.270  0.52
2002 Baggott MJ. Preventing problems in Ecstasy users: reduce use to reduce harm. Journal of Psychoactive Drugs. 34: 145-62. PMID 12691205 DOI: 10.1080/02791072.2002.10399949  0.96
2002 Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones RT. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology. 162: 396-405. PMID 12172693 DOI: 10.1007/S00213-002-1131-1  0.96
2001 Vollenweider FX, Jones RT, Baggott MJ. Caveat emptor: editors beware. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 461-3. PMID 11310414 DOI: 10.1016/S0893-133X(00)00170-6  0.56
2001 Mendelson J, Herbst E, Heifets B, Baggott M, Jacob P, Everhart ET, Jones RT. The effect of route of cocaine administration on cocaethylene formation Clinical Pharmacology and Therapeutics. 69: P29.  0.96
2000 Lester SJ, Baggott M, Welm S, Schiller NB, Jones RT, Foster E, Mendelson J. Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial. Annals of Internal Medicine. 133: 969-73. PMID 11119398 DOI: 10.7326/0003-4819-133-12-200012190-00012  0.96
2000 Baggott M, Heifets B, Jones RT, Mendelson J, Sferios E, Zehnder J. Chemical analysis of ecstasy pills. Jama. 284: 2190. PMID 11056589 DOI: 10.1001/Jama.284.17.2190  0.96
1999 Borg GJ. More about parkinsonism after taking ecstasy. The New England Journal of Medicine. 341: 1400; author reply 1. PMID 10577095 DOI: 10.1056/NEJM199910283411815  0.96
1999 Mendelson J, Jones RT, Welm S, Baggott M, Fernandez I, Melby AK, Nath RP. Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers. Psychopharmacology. 141: 37-46. PMID 9952063 DOI: 10.1007/S002130050804  0.96
1997 Jacob P, Mendelson J, Everhart ET, Nath R, Baggott M, Welm S, Jones RT. Formation and elimination of cocaethylene in humans Clinical Pharmacology and Therapeutics. 61: 222.  0.96
1996 Mendelson J, Jones RT, Fernandez I, Welm S, Melby AK, Baggott MJ. Buprenorphine and naloxone interactions in opiate-dependent volunteers. Clinical Pharmacology and Therapeutics. 60: 105-14. PMID 8689806 DOI: 10.1016/S0009-9236(96)90173-3  0.96
1993 Richards JB, Baggott MJ, Sabol KE, Seiden LS. A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task. Brain Research. 627: 254-60. PMID 8298969 DOI: 10.1016/0006-8993(93)90328-K  0.96
Show low-probability matches.